Equities research analysts expect Sapiens International Co. (NASDAQ:SPNS) to announce $73.85 million in sales for the current quarter, according to Zacks. Two analysts have made estimates for Sapiens International’s earnings. The lowest sales estimate is $73.19 million and the highest is $74.50 million. Sapiens International posted sales of $57.11 million during the same quarter last year, which suggests a positive year-over-year growth rate of 29.3%. The firm is scheduled to announce its next quarterly earnings results on Tuesday, February 27th.
On average, analysts expect that Sapiens International will report full year sales of $73.85 million for the current fiscal year, with estimates ranging from $270.78 million to $274.00 million. For the next financial year, analysts forecast that the business will post sales of $304.56 million per share, with estimates ranging from $300.20 million to $308.92 million. Zacks Investment Research’s sales averages are an average based on a survey of research firms that cover Sapiens International.
Sapiens International (NASDAQ:SPNS) last posted its earnings results on Thursday, November 9th. The technology company reported $0.12 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.11 by $0.01. Sapiens International had a net margin of 0.38% and a return on equity of 6.84%.
Shares of Sapiens International (NASDAQ:SPNS) opened at $12.15 on Friday. Sapiens International has a 12-month low of $10.57 and a 12-month high of $15.46. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.03 and a quick ratio of 2.03. The company has a market cap of $612.24 and a PE ratio of 607.80.
Large investors have recently bought and sold shares of the company. Citigroup Inc. increased its stake in shares of Sapiens International by 345.1% in the 2nd quarter. Citigroup Inc. now owns 40,037 shares of the technology company’s stock worth $448,000 after acquiring an additional 31,041 shares in the last quarter. Dimensional Fund Advisors LP bought a new position in shares of Sapiens International in the 2nd quarter worth about $358,000. Goldman Sachs Group Inc. increased its stake in shares of Sapiens International by 93.2% in the 2nd quarter. Goldman Sachs Group Inc. now owns 320,428 shares of the technology company’s stock worth $3,586,000 after acquiring an additional 154,555 shares in the last quarter. BlueCrest Capital Management Ltd bought a new position in shares of Sapiens International in the 2nd quarter worth about $178,000. Finally, Migdal Insurance & Financial Holdings Ltd. bought a new position in shares of Sapiens International in the 2nd quarter worth about $12,985,000. 9.16% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: This report was first reported by American Banking News and is the sole property of of American Banking News. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/02/03/zacks-analysts-expect-sapiens-international-co-spns-will-post-quarterly-sales-of-73-85-million.html.
About Sapiens International
Sapiens International Corporation N.V. (Sapiens) is a provider of software solutions for the insurance industry, with a focus on the financial services sector. The Company operates in provider of software solutions segment. Its software solutions portfolio consists of Life, Pension, Annuity and Retirement Solutions, including software solutions for the management of a range of products for life, pension, annuity and retirement; Property and Casualty/General Insurance Solutions, including a software suite of solutions, supporting a range of business lines, including personal, commercial and specialty lines, as well as a solution for the management of reinsurance contracts; Sapiens DECISION, which is a business decision management solution, and Technology-Based Solutions, such as Sapiens eMerge.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sapiens International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sapiens International and related companies with MarketBeat.com's FREE daily email newsletter.